Physician profile
Kim King
NPI 1801567631
$1,803.63
in general payments reported to CMS, 2019-2025
15 companies · $376 in 2025
The $376 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $342 · 2023: $344 · 2024: $742 · 2025: $376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,462.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,461.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $245.61 | 2023-2024 | Repatha, Otezla |
| Astrazeneca Pharmaceuticals LP | $245.25 | 2024-2025 | Wainua, Datroway |
| Bayer Healthcare Pharmaceuticals INC. | $144.87 | 2025 | |
| Madrigal Pharmaceuticals | $142.45 | 2024 | Rezdiffra |
| Hologic Sales and Service, LLC | $126.82 | 2023 | Aptima |
| Mayne Pharma Commercial LLC | $124.70 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $121.58 | 2024 | Rexulti |
| Regeneron Healthcare Solutions, INC. | $121.58 | 2022 | |
| Scynexis, INC. | $116.62 | 2022 | |
| Abbvie INC. | $109.37 | 2024 | |
| Stryker Corporation | $108.93 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Teva Pharmaceuticals USA, INC. | $103.60 | 2022 | |
| Glaxosmithkline, LLC. | $42.37 | 2023 | Trelegy Ellipta |
| Lilly USA, LLC | $25.23 | 2023 | Mounjaro |
| Scilex Pharmaceuticals INC. | $24.65 | 2023 | Ztlido |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kim King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.